Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03034096 · ClinicalTrials.gov registry record · Phase 4
General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial
A Phase 4 study, sponsored by Stony Brook University.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,826
- Enrollment target
NCT03034096 is a Phase 4 study that has completed, run by Stony Brook University. The registered enrollment target is 1,826 participants.
The verdict
NCT03034096, a Phase 4 study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,826 participants
- Enrollment target
Study Summary
This is a large pragmatic multicenter trial comparing maintenance of general anesthesia with total intravenous anesthesia using propofol versus volatile agent (sevoflurane, isoflurane, or desflurane) during cancer surgery. The primary endpoint is all-cause mortality.
Interventions
- DRUG Propofol
- DRUG Volatile Agent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,826 participants |
| Start Date | 2017-01-31 |
| Est. Completion | 2024-09-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03034096
The ClinicalTrials.gov registry entry for NCT03034096 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,826 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Propofol is the first listed.
NCT03034096 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03034096 about?
NCT03034096 is a clinical study titled "General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial". This is a large pragmatic multicenter trial comparing maintenance of general anesthesia with total intravenous anesthesia using propofol versus volatile agent (sevoflurane, isoflurane, or desflurane) during cancer surgery. The primary endpoint is all-cause mortality.
What is the current status of trial NCT03034096?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,826 participants. The study started on 2017-01-31. Estimated completion is 2024-09-30.
What interventions are being tested in trial NCT03034096?
The interventions under investigation include: Propofol (DRUG), Volatile Agent (DRUG).
Who is sponsoring clinical trial NCT03034096?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.